XGN - Exagen Inc.
NASDAQ
->
Healthcare
->
Diagnostics & Research
Vista,
United States
Type: Equity
XGN price evolution
XGN
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $36.49 | $28.45 | $31.47 | $52.18 |
| Short term investments | ||||
| Net receivables | $6.55 | $17.04 | $16.23 | $9.3 |
| Inventory | ||||
| Total current assets | $47.84 | $48.91 | $51.27 | $65.72 |
| Long term investments | ||||
| Property, plant & equipment | $8.49 | $11.38 | $12.29 | $12.91 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $9.1 | $12.02 | $12.91 | $13.52 |
| Total investments | ||||
| Total assets | $56.94 | $60.93 | $64.18 | $79.23 |
| Current liabilities | ||||
| Accounts payable | $3.13 | $1.66 | $1.31 | $1.88 |
| Deferred revenue | ||||
| Short long term debt | $1.24 | $1.4 | $1.36 | $1.33 |
| Total current liabilities | $11.9 | $10.12 | $8.6 | $9.27 |
| Long term debt | $21.99 | $22.82 | $23.08 | $33.3 |
| Total noncurrent liabilities | $22.35 | $23.3 | $23.67 | $34.03 |
| Total debt | $23.23 | $24.22 | $24.44 | $34.63 |
| Total liabilities | $34.25 | $33.42 | $32.28 | $43.3 |
| Shareholders' equity | ||||
| Retained earnings | -$279.22 | -$273.64 | -$268.23 | -$263.21 |
| Other shareholder equity | ||||
| Total shareholder equity | $22.69 | $27.5 | $31.9 | $35.94 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $36.49 | $62.39 | $99.44 | $57.45 |
| Short term investments | ||||
| Net receivables | $6.55 | $6.08 | $9.65 | $8.91 |
| Inventory | $1.2 | |||
| Total current assets | $47.84 | $72.61 | $112.73 | $70.52 |
| Long term investments | ||||
| Property, plant & equipment | $8.49 | $13.08 | $4.77 | $2.1 |
| Goodwill & intangible assets | $5.51 | $5.51 | ||
| Total noncurrent assets | $9.1 | $13.61 | $10.71 | $7.86 |
| Total investments | ||||
| Total assets | $56.94 | $86.22 | $123.44 | $78.38 |
| Current liabilities | ||||
| Accounts payable | $3.13 | $3.05 | $2.49 | $3.01 |
| Deferred revenue | ||||
| Short long term debt | $1.24 | $1.23 | ||
| Total current liabilities | $11.9 | $9.62 | $9.32 | $8.77 |
| Long term debt | $21.99 | $29.63 | $27.48 | $26.66 |
| Total noncurrent liabilities | $22.35 | $34.14 | $29.19 | $27.77 |
| Total debt | $23.23 | $34.5 | $27.48 | $26.66 |
| Total liabilities | $34.25 | $43.76 | $38.51 | $36.54 |
| Shareholders' equity | ||||
| Retained earnings | -$279.22 | -$255.53 | -$208.14 | -$181.29 |
| Other shareholder equity | ||||
| Total shareholder equity | $22.69 | $42.46 | $84.94 | $41.84 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $13.77 | $13.42 | $14.14 | $11.23 |
| Cost of revenue | $5.62 | $5.71 | $5.84 | $5.93 |
| Gross Profit | $8.14 | $7.71 | $8.3 | $5.3 |
| Operating activities | ||||
| Research & development | $1.08 | $1.4 | $1.26 | $1.13 |
| Selling, general & administrative | $12.22 | $11.38 | $11.95 | $11.88 |
| Total operating expenses | $13.29 | $12.78 | $13.22 | $13.01 |
| Operating income | -$5.15 | -$5.07 | -$4.92 | -$7.71 |
| Income from continuing operations | ||||
| EBIT | -$4.97 | -$4.86 | -$4.44 | -$7.05 |
| Income tax expense | $0.03 | |||
| Interest expense | $0.57 | $0.56 | $0.57 | $0.64 |
| Net income | ||||
| Net income | -$5.57 | -$5.42 | -$5.01 | -$7.69 |
| Income (for common shares) | -$5.57 | -$5.42 | -$5.01 | -$7.69 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $52.55 | $45.56 | $48.3 | $41.98 |
| Cost of revenue | $23.09 | $24.21 | $20.59 | $16.56 |
| Gross Profit | $29.46 | $21.35 | $27.71 | $25.42 |
| Operating activities | ||||
| Research & development | $4.87 | $9.88 | $7.24 | $3.57 |
| Selling, general & administrative | $47.43 | $52.02 | $44.54 | $37.03 |
| Total operating expenses | $52.29 | $67.4 | $51.78 | $40.6 |
| Operating income | -$22.84 | -$46.05 | -$24.07 | -$15.19 |
| Income from continuing operations | ||||
| EBIT | -$21.32 | -$45.22 | -$24.05 | -$14.2 |
| Income tax expense | $0.03 | -$0.28 | $0.17 | -$0.08 |
| Interest expense | $2.33 | $2.45 | $2.63 | $2.56 |
| Net income | ||||
| Net income | -$23.69 | -$47.39 | -$26.85 | -$16.69 |
| Income (for common shares) | -$23.69 | -$47.39 | -$26.85 | -$16.69 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | -$5.57 | -$5.42 | -$5.01 | -$7.69 |
| Operating activities | ||||
| Depreciation | $0.73 | $0.85 | $0.74 | $0.79 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $0.76 | $0.89 | $0.98 | $0.99 |
| Total cash flows from operations | $8.35 | -$2.91 | -$10.15 | -$9.75 |
| Investing activities | ||||
| Capital expenditures | -$0.08 | -$0 | -$0.32 | -$0.4 |
| Investments | ||||
| Total cash flows from investing | -$0.08 | -$0 | -$0.32 | -$0.4 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.13 | $0.18 | ||
| Net borrowings | -$0.22 | -$0.23 | -$10.24 | -$0.24 |
| Total cash flows from financing | -$0.22 | -$0.11 | -$10.24 | -$0.06 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $8.04 | -$3.02 | -$20.72 | -$10.21 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$23.69 | -$47.39 | -$26.85 | -$16.69 |
| Operating activities | ||||
| Depreciation | $3.11 | $2.52 | $0.95 | $0.55 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $3.62 | $4.7 | $4.73 | $2.69 |
| Total cash flows from operations | -$14.46 | -$32.14 | -$20.27 | -$14.08 |
| Investing activities | ||||
| Capital expenditures | -$0.8 | -$4.32 | -$2.37 | -$0.46 |
| Investments | ||||
| Total cash flows from investing | -$0.8 | -$4.32 | -$2.42 | -$0.46 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.31 | $0.45 | $65.25 | $0.16 |
| Net borrowings | -$10.94 | -$0.7 | -$0.53 | -$0.25 |
| Total cash flows from financing | -$10.63 | -$0.49 | $64.68 | -$0.1 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$25.9 | -$36.95 | $41.99 | -$14.64 |
News
Fundamentals
| Market cap | $26.76M |
|---|---|
| Enterprise value | $13.50M |
| Shares outstanding | 17.05M |
| Revenue | $52.55M |
|---|---|
| EBITDA | -$18.21M |
| EBIT | -$21.32M |
| Net Income | -$23.69M |
| Revenue Q/Q | 7.23% |
| Revenue Y/Y | N/A |
| P/E ratio | -1.13 |
|---|---|
| EV/Sales | 0.26 |
| EV/EBITDA | -0.74 |
| EV/EBIT | -0.63 |
| P/S ratio | 0.51 |
| P/B ratio | 1.18 |
| Book/Share | 1.33 |
| Cash/Share | 2.14 |
| EPS | -$1.39 |
|---|---|
| ROA | -36.27% |
| ROE | -80.28% |
| Debt/Equity | 1.51 |
|---|---|
| Net debt/EBITDA | 0.12 |
| Current ratio | 4.02 |
| Quick ratio | 4.02 |